Stacey GandlerBrand Nourishment
David LinetskyPoint-of-Care Marketing
Matt TurnerPatient Affordability
Brenda SnowAuthentic Patient Voice
Frank BurrellScientific Storytelling
Liz KaneImpactful Strategy
Joey CohenMedication Adherence
Suma Ramadas, PhDMedical Affairs
Daniel SontupeMarket Access
Matthew DurhamOmnidynamic Marketing
Bud BilanichSuccess Coach
Paul TheisenPatient Acquisition
Amy GilesIncreasing Engagement
Pat PurcellMeeting Engagement
Investigational therapy crizanlizumab (SEG101, formerly SelG1) approximately doubled the time to first on-treatment sickle ...
All PLX-treated groups showed improvements in survival rates compared to untreated groups PLX-R18 cells ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email